(MENAFN- Comserve) Shibuya-ku, Tokyo, Japan, Japan, May 07, 2021, 05:38 /Comserve / -- The report analyze market size, share, growth, trends, segmentation, top key players, strategies, demand, statistics, competitive landscape and forecast.
The factors that are driving the market growth include advantages offered by particle therapy and the growing global prevalence of cancer.
The number of people suffering from various cancers has been found to be a major driving factor for this market. Cancer is one of the major life-threatening diseases of our times. According to the WHO, cancer is the second leading cause of death, globally, and was responsible for an estimated 9.6 million deaths in 2018. Globally, about one in six deaths are due to cancer. Approximately 70% of deaths from cancer occur in low and middle-income countries. Since particle therapies are used to treat cancer, the growing prevalence of the same is expected to be the major driver of the growth of this market.
Key Market Trends
Click Here to Download Sample Report >>
Application of Particle Therapy in Lung Cancer is Expected to Hold a Significant Share Over the Forecast Period
When treating lung cancer with traditional radiation, it can be difficult to deliver an effective dose without risking damage to healthy tissue. By using proton therapy for lung cancer treatment, physicians may be able to deliver highly effective and very precise doses of protons to the exact location of lung cancer. Proton therapy for lung cancer has proven to be a reasonable treatment for patients whose cancer is limited to the chest.
Moreover, lung cancer is the leading form of cancer and cause of death globally, as per a 2018 report by the World Health Organization. As per the report, there were 2.09 million cases and 1.76 million due to lung cancer which was the highest among all the cancers. This factor is expected to increase the demand for more effective therapies like particle therapy, which will boost the market growth.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America has dominated the global market studied, in 2018. Almost half of all cancer patients in the region, especially in the United States receive cancer treatment. The United States has the largest market for radiotherapy.
The market is driven by factors, such as increasing incidences of cancer, replacements of older therapies with newer ones, and the availability of reimbursements for radiation therapy. A few states in the United States have passed laws compelling the personnel performing radiologic procedures to hold licenses. The changes in legislature and availability of reimbursement policies have led to incentivizing the providers to improve patient care and outcomes of treatment while controlling the costs. With large investments being made in R & D of innovative technologies for particle therapy, the market is expected to grow during the forecast period.
Competitive Landscape
The global Particle Therapy market is moderately competitive and consists of a number of major players. Companies like Danfysik A/S, Hitachi, Ltd., Ion Beam Applications Sa (IBA), Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., Protom International, Inc., Provision Healthcare, LLC, Sumitomo Heavy Industries, Ltd., Varian Medical Systems, Inc., among others, hold the substantial market share in the Particle Therapy market.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Request For Full Report >>
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Advantages Offered By Particle Therapy
4.2.2 Growing Global Burden of Cancer
4.3 Market Restraints
4.3.1 Infrastructural Challenges in Healthcare Facilities
4.3.2 Unfavorable Reimbursement Policies and Limited Insurance Coverage
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Proton Therapy
5.1.2 Heavy Ion Therapy
5.2 By System
5.2.1 Multi-Room Systems
5.2.2 Single-Room Systems
5.3 By Cancer Type
5.3.1 Pediatric Cancer
5.3.2 Prostate Cancer
5.3.3 Lung Cancer
5.3.4 Breast Cancer
5.3.5 Brain and Spinal Cord Cancer
5.3.6 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Rest of World
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Danfysik A/S
6.1.2 Hitachi, Ltd.
6.1.3 Ion Beam Applications Sa (IBA)
6.1.4 Mevion Medical Systems, Inc.
6.1.5 Optivus Proton Therapy, Inc.
6.1.6 Protom International, Inc.
6.1.7 Provision Healthcare, LLC
6.1.8 Sumitomo Heavy Industries, Ltd.
6.1.9 Varian Medical Systems, Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.
For more information, please contact:
Hina Miyazu Shibuya Data Count
Email:
Tel: + 81 3 45720790
MENAFN07052021004694010674ID1102046381
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.